Aqua Medical Treats First West Coast Patient in FDA-Approved IDE Trial of Investigational PIMA Procedure for Type 2 Diabetes
Latest PR Newswire FDA coverage of Aqua Medical Treats First West Coast Patient in FDA-Approved IDE Trial of Invest
Services: Medical device company providing disruptive vapor-based endoscopic ablation therapy for gastrointestinal diseases; developing Aqua Endoscopy system for GI disease treatment.
Q2 2026 corporate update
Latest PR Newswire FDA coverage of Aqua Medical Treats First West Coast Patient in FDA-Approved IDE Trial of Invest
Aqua Medical named Bob Haggerty as CEO as the company targets type 2 diabetes.